Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
Gov. Lee's budget amendment proposes $40 million for a bridge to support what is the largest economic development announcement in state history. The convention center's board took a step March 24 ...
A Monte Carlo and decision-tree risk analysis of a U.S. plan to seize Kharg Island and its impact on oil prices, war risk, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results